Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
824.00M | 791.00M | 679.00M | 635.00M | 741.00M |
Gross Profit | ||||
500.00M | 412.00M | 372.00M | 416.00M | 500.00M |
EBIT | ||||
-227.00M | 414.00M | 385.00M | 306.00M | 472.00M |
EBITDA | ||||
-231.00M | -527.00M | 388.00M | -1.31B | -737.00M |
Net Income Common Stockholders | ||||
-319.00M | -619.00M | 869.00M | -1.39B | -832.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
78.00M | 41.00M | 146.00M | 5.00M | 1.34B |
Total Assets | ||||
10.66B | 10.97B | 12.89B | 10.99B | 14.36B |
Total Debt | ||||
3.78B | 3.54B | 4.55B | 3.52B | 5.33B |
Net Debt | ||||
3.70B | 3.50B | 4.41B | 3.58B | 3.99B |
Total Liabilities | ||||
4.22B | 3.89B | 4.90B | 3.78B | 5.61B |
Stockholders Equity | ||||
6.40B | 7.00B | 7.92B | 7.21B | 8.75B |
Cash Flow | Free Cash Flow | |||
212.00M | 240.00M | 339.00M | 15.00M | 200.00M |
Operating Cash Flow | ||||
338.00M | 342.00M | 381.00M | 233.00M | 401.00M |
Investing Cash Flow | ||||
-272.00M | 834.00M | -607.00M | 334.00M | -116.00M |
Financing Cash Flow | ||||
-29.00M | -1.28B | 362.00M | -1.91B | 1.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $6.04B | 26.78 | 6.21% | 3.99% | 24.84% | -6.90% | |
74 Outperform | $3.06B | 18.84 | 5.37% | 7.58% | -2.08% | 3.63% | |
72 Outperform | $12.95B | 28.30 | 5.38% | 6.17% | -9.09% | -36.58% | |
70 Outperform | $2.24B | 28.32 | 5.97% | 4.14% | 6.73% | -71.83% | |
61 Neutral | $4.26B | 15.61 | -3.60% | 11.29% | 6.17% | -21.11% | |
60 Neutral | $1.74B | ― | -5.48% | 15.38% | 56.29% | 55.99% | |
45 Neutral | $5.11B | 37.27 | 1.66% | 4.70% | 1.49% | ― |